Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration‐resistant prostate cancer.
Saved in:
| Title: | Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration‐resistant prostate cancer. |
|---|---|
| Authors: | Fenioux, Charlotte1 (AUTHOR) charlotte.fenioux@gmail.com, Louvet, Christophe1 (AUTHOR), Charton, Emilie2 (AUTHOR), Rozet, Francois3 (AUTHOR), Ropert, Stanislas4 (AUTHOR), Prapotnich, Dominique3 (AUTHOR), Barret, Eric3 (AUTHOR), Sanchez‐Salas, Rafael3 (AUTHOR), Mombet, Annick3 (AUTHOR), Cathala, Nathalie3 (AUTHOR), Joulia, Marie‐Liesse1 (AUTHOR), Molitor, Jean‐Luc1 (AUTHOR), Henriques, Julie2 (AUTHOR), Bonnetain, Franck2 (AUTHOR), Cathelineau, Xavier3 (AUTHOR), Bennamoun, Mostefa1 (AUTHOR) |
| Source: | BJU International. Feb2019, Vol. 123 Issue 2, p300-306. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
